Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy [Phase 2]
Phase 2 clinical trial update comparing sacituzumab govitecan with bevacizumab to standard chemotherapy for recurrent platinum-sensitive ova…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence [Phase 2]
This entry describes a Phase 2 clinical trial of an IGFBP-2 vaccine to prevent ovarian cancer progression in patients with serologic evidenc…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating Ubamatamab in combination therapy for adults with platinum-resistant ovarian cancer; recruitment is ongo…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer [Phase 1]
A Phase 1 clinical trial evaluating Azenosertib (ZN-c3) in patients with epithelial ovarian cancer and other solid tumors is currently recru…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT [Phase 1]
Phase I pilot study to characterize biodistribution, metabolism, and excretion of the novel PET radiotracer [18F]Fluorthanatrace (FTT) using…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies [Phase 2]
This Phase 2 trial investigates changes in disease activity and safety in adults with gynecologic cancers treated with IMGN151, either alone…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating a cancer vaccine therapy in combination with pembrolizumab for advanced fallopian tube, primary per…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. [Phase 2]
Clinical trial update for a Phase 2 study evaluating a combination of oregovomab and niraparib in platinum-sensitive recurrent ovarian cance…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas [Phase 2]
Clinical trial BrUOG 354 assesses nivolumab with or without ipilimumab in ovarian and extrarenal (clear cell) carcinomas; the Phase 2 study …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]
FT536 is being evaluated in a Phase 1 trial for recurrent ovarian cancer, fallopian tube cancer, and primary peritoneal cancer, and the stud…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Clinical trial update for a Phase 1 drug-drug interaction study evaluating AZD5335 with itraconazole in ovarian-, fallopian tube-, or primar…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery [Phase 2]
Phase 2 clinical trial update on acute normovolemic hemodilution in patients with ovarian cancer undergoing cytoreductive surgery; currently…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery [Phase 3]
A Phase 3 trial of oregovomab plus chemotherapy for newly diagnosed advanced epithelial ovarian cancer after optimal debulking surgery is cu…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Using Aspirin to Improve Immunological Features of Ovarian Tumors [EARLY_Phase 1]
Phase 1 trial is exploring whether aspirin can improve the immunological features of ovarian tumors and related cancers. The study is curren…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma [NA]
A prospective clinico-biological database study for patients with ovarian cancer, fallopian tube cancer, or peritoneal cancer is currently r…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer [Phase 1]
Phase 1 clinical trial update on the safety and immunogenicity of Innocell Autologous Cellular Immunotherapy for recurrent epithelial ovaria…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 clinical trial update for GB-5267 in platinum-resistant ovarian, peritoneal, or fallopian tube cancer; the study is not yet recruiti…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 study is investigating Benmelstobart in combination with Anlotinib and oral metronomic cyclophosphamide for recurrent epithelial o…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer [Phase 3]
An ongoing Phase 3 trial evaluates the PARP inhibitor olaparib, alone or with bevacizumab, for patients with ovarian, fallopian tube, or pri…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion [Phase 2]
Phase 2 trial evaluating APL-2 with pembrolizumab versus APL-2 with pembrolizumab plus bevacizumab versus bevacizumab alone for recurrent ov…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating dual-targeting CAR-NK cells against MSLN, FRα, and MUC16 for recurrent epithelial ovarian cancer, primar…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) [Phase 3]
Phase 3 clinical trial evaluating Olvi-Vec in combination with platinum-doublet chemotherapy and Bevacizumab versus physician's choice of ch…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
ART0380 is being studied in a Phase 1/2 trial for various advanced or metastatic solid tumors and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer [NA]
Clinical trial update on risk-reducing strategies, including fimbriectomy, for women with germline mutations predisposing to ovarian or pelv…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluates a PARP inhibitor with or without an angiogenesis inhibitor in patients with homologous recombinat…